secwatch / observer
8-K filed November 23, 2022, 6:59 PM ET ticker ROIV CIK 0001635088
leadership confidence high sentiment neutral materiality 0.30

Director Andrew Lo resigns from Roivant Sciences board effective Nov 17, 2022

Roivant Sciences Ltd.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andrew Lo

Class II director
ROIV · Roivant Sciences Ltd.
Effective
2022-11-17
Filed
November 23, 2022, 6:59 PM ET
On November 17, 2022, Dr. Andrew Lo, a Class II director of Roivant Sciences Ltd. (the “Company”), informed the Company of his decision to resign from his role on the Company’s board of directors (the “Board”) effective immediately, to focus on other ventures.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Lo resigned as Class II director at Roivant Sciences Ltd..

Action
resigned
Role
Class II director
Exact text from the filing
On November 17, 2022, Dr. Andrew Lo, a Class II director of Roivant Sciences Ltd. (the “Company”), informed the Company of his decision to resign from his role on the Company’s board of directors (the “Board”) effective immediately, to focus on other ventures.
View on SEC.gov

Roivant Sciences Ltd. filing history →

Source: SEC EDGAR
accession 0001140361-22-043040
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.